Genagon Therapeutics Genagon Therapeutics is a company that aims to increase response rates in immuno-oncology. | ![]() Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. | ||||
Founding Date | Founding Date 2015 | Founding Date 1953 | Founding Date 2003 | Founding Date 2016 | Founding Date 2010 |
Type | Type Private | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Solna, SE HQ | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations London, GB HQ Stevenage, GB | Locations TW HQ | |
Employees | Employees 730% decrease | Employees 17,3684% decrease | Employees 2414% decrease | Employees 695% decrease | Employees 76 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) NT$1.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $230k (FY, 2025) | Cost of goods N/A | Cost of goods NT$629m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $950k (FY, 2025) | Gross profit N/A | Gross profit NT$709.7m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($2m) (FY, 2025) | Net income ($69.7m) (FY, 2023) | Net income NT$187.8m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 233.3k (over 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 121m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 233.3k | Total funding raised N/A | Total funding raised $ 100.9m | Total funding raised $ 138.1m | Total funding raised N/A |
Janssen is a company providing prescription pharmaceutical products.
View company
BioLineRx is a biopharmaceutical company focused on oncology.
View company
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View company
TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases.
View company